Immunological sequestration of ALK1 ligands (using ALK1-Fc) or antibody against ALK1 inhibits tumor angiogenesis and tumor growth of mouse model of pancreatic cancer, breast cancer, and melanoma (Roman and Hinck, 2017). Here, ACVRL1 is linked to breast carcinoma.